(-)-demecolcine increases expression ISO RGD:733081 6480464 Demecolcine results in increased expression of NRP1 mRNA CTD PMID:23649840 1,1-dichloroethene decreases expression EXP 6480464 vinylidene chloride results in decreased expression of NRP1 mRNA CTD PMID:26682919 17alpha-ethynylestradiol increases expression ISO RGD:733081 6480464 Ethinyl Estradiol results in increased expression of NRP1 mRNA CTD PMID:18936297 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of NRP1 mRNA CTD PMID:14664709 17beta-estradiol increases expression ISO RGD:621588 6480464 Estradiol results in increased expression of NRP1 mRNA CTD PMID:35192832 17beta-estradiol multiple interactions ISO RGD:621588 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NRP1 mRNA CTD PMID:32741896 17beta-estradiol increases expression ISO RGD:733081 6480464 Estradiol results in increased expression of NRP1 mRNA CTD PMID:31646340 17beta-estradiol multiple interactions ISO RGD:733081 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of NRP1 mRNA, Fulvestrant inhibits the reaction [Estradiol results in increased expression of NRP1 mRNA] CTD PMID:20660070 , PMID:31646340 17beta-estradiol 3-benzoate multiple interactions ISO RGD:621588 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NRP1 mRNA CTD PMID:32741896 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:733081 6480464 2 more ... CTD PMID:19095052 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733081 6480464 Tetrachlorodibenzodioxin affects the expression of NRP1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:621588 6480464 Tetrachlorodibenzodioxin affects the expression of NRP1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:621588 6480464 Tetrachlorodibenzodioxin results in increased expression of NRP1 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NRP1 mRNA CTD PMID:19770486 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733081 6480464 Tetrachlorodibenzodioxin results in increased expression of NRP1 mRNA CTD PMID:20106945 , PMID:21632981 2,4,6-tribromophenol increases expression ISO RGD:733081 6480464 2 more ... CTD PMID:31675489 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:733081 6480464 tetrabromobisphenol A results in increased expression of NRP1 protein CTD PMID:31675489 3,3',5-triiodo-L-thyronine increases expression ISO RGD:621588 6480464 Triiodothyronine results in increased expression of NRP1 mRNA CTD PMID:15953391 3-chloropropane-1,2-diol increases expression ISO RGD:621588 6480464 alpha-Chlorohydrin results in increased expression of NRP1 mRNA CTD PMID:28522335 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:733081 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRP1 mRNA CTD PMID:28628672 3-Nitrobenzanthrone increases expression ISO RGD:733081 6480464 3-nitrobenzanthrone results in increased expression of NRP1 mRNA CTD PMID:34036453 3H-1,2-dithiole-3-thione decreases expression ISO RGD:621588 6480464 1, 2-dithiol-3-thione results in decreased expression of NRP1 mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol decreases expression ISO RGD:733081 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of NRP1 mRNA CTD PMID:25912373 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of NRP1 mRNA CTD PMID:30951980 4-hydroxynon-2-enal increases expression EXP 6480464 4-hydroxy-2-nonenal results in increased expression of NRP1 mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of NRP1 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine multiple interactions ISO RGD:733081 6480464 [Decitabine co-treated with Depsipeptides] results in decreased expression of NRP1 mRNA, Decitabine inhibits the reaction [Smoke results in decreased expression of NRP1 mRNA] CTD PMID:17064661 , PMID:21095227 5-fluorouracil decreases response to substance ISO RGD:733081 6480464 NRP1 protein results in decreased susceptibility to Fluorouracil CTD PMID:15956974 8-Br-cAMP increases expression ISO RGD:733081 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NRP1 mRNA CTD PMID:22079614 acetaldehyde affects expression EXP 6480464 Acetaldehyde affects the expression of NRP1 mRNA CTD PMID:22634333 acetamide increases expression ISO RGD:621588 6480464 acetamide results in increased expression of NRP1 mRNA CTD PMID:31881176 acrylamide decreases expression ISO RGD:621588 6480464 Acrylamide results in decreased expression of NRP1 mRNA CTD PMID:28959563 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of NRP1 mRNA CTD PMID:19770486 aflatoxin B1 increases expression ISO RGD:733081 6480464 Aflatoxin B1 results in increased expression of NRP1 mRNA CTD PMID:27153756 aflatoxin B1 affects expression ISO RGD:733081 6480464 Aflatoxin B1 affects the expression of NRP1 protein CTD PMID:20106945 all-trans-retinoic acid increases expression ISO RGD:733081 6480464 Tretinoin results in increased expression of NRP1 mRNA CTD PMID:21934132 , PMID:33167477 all-trans-retinoic acid decreases expression ISO RGD:733081 6480464 Tretinoin results in decreased expression of NRP1 mRNA CTD PMID:23724009 ammonium chloride affects expression ISO RGD:621588 6480464 Ammonium Chloride affects the expression of NRP1 mRNA CTD PMID:16483693 amphetamine decreases expression ISO RGD:621588 6480464 Amphetamine results in decreased expression of NRP1 mRNA CTD PMID:30779732 antimycin A decreases expression EXP 6480464 Antimycin A results in decreased expression of NRP1 mRNA CTD PMID:19304788 aristolochic acid A decreases expression ISO RGD:733081 6480464 aristolochic acid I results in decreased expression of NRP1 mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:733081 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of NRP1 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:733081 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of NRP1 mRNA CTD PMID:32525701 arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of NRP1 mRNA CTD PMID:33053406 arsenite(3-) increases expression ISO RGD:733081 6480464 arsenite results in increased expression of NRP1 mRNA CTD PMID:31646340 arsenite(3-) multiple interactions ISO RGD:733081 6480464 Fulvestrant inhibits the reaction [arsenite results in increased expression of NRP1 mRNA] CTD PMID:31646340 arsenite(3-) increases methylation ISO RGD:733081 6480464 arsenite results in increased methylation of NRP1 promoter CTD PMID:23974009 belinostat increases expression ISO RGD:733081 6480464 belinostat results in increased expression of NRP1 mRNA CTD PMID:26272509 belinostat multiple interactions ISO RGD:733081 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP1 mRNA CTD PMID:27188386 benzo[a]pyrene decreases expression ISO RGD:733081 6480464 Benzo(a)pyrene results in decreased expression of NRP1 mRNA CTD PMID:20064835 benzo[a]pyrene increases expression ISO RGD:733081 6480464 Benzo(a)pyrene results in increased expression of NRP1 mRNA CTD PMID:20106945 more ... benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of NRP1 mRNA CTD PMID:19770486 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:733081 6480464 7 more ... CTD PMID:19150397 , PMID:20382639 bicalutamide decreases expression ISO RGD:733081 6480464 bicalutamide results in decreased expression of NRP1 mRNA CTD PMID:15638997 bisphenol A affects expression ISO RGD:733081 6480464 bisphenol A affects the expression of NRP1 mRNA CTD PMID:20170705 bisphenol A increases methylation ISO RGD:733081 6480464 bisphenol A results in increased methylation of NRP1 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:733081 6480464 bisphenol A results in decreased expression of NRP1 protein CTD PMID:31675489 bisphenol A decreases expression ISO RGD:621588 6480464 bisphenol A results in decreased expression of NRP1 mRNA CTD PMID:34947998 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NRP1 mRNA CTD PMID:30951980 more ... bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of NRP1 promoter CTD PMID:27312807 bisphenol A multiple interactions ISO RGD:733081 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRP1 mRNA CTD PMID:28628672 bisphenol A affects expression ISO RGD:621588 6480464 bisphenol A affects the expression of NRP1 mRNA CTD PMID:25181051 , PMID:30816183 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of NRP1 mRNA CTD PMID:26063408 Bisphenol A diglycidyl ether multiple interactions EXP 6480464 [2, 2-bis(4-glycidyloxyphenyl)propane co-treated with Cytarabine] results in decreased expression of NRP1 mRNA CTD PMID:23264188 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of NRP1 mRNA CTD PMID:30951980 butanal decreases expression ISO RGD:733081 6480464 butyraldehyde results in decreased expression of NRP1 mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO RGD:733081 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NRP1 mRNA, Cadmium inhibits the reaction [Fulvestrant results in decreased expression of NRP1 mRNA] CTD PMID:31646340 , PMID:35301059 cadmium atom increases expression ISO RGD:733081 6480464 Cadmium results in increased expression of NRP1 mRNA CTD PMID:31646340 cadmium dichloride multiple interactions ISO RGD:733081 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NRP1 mRNA CTD PMID:35301059 calcitriol decreases expression ISO RGD:733081 6480464 Calcitriol results in decreased expression of NRP1 mRNA CTD PMID:16002434 capsaicin increases expression ISO RGD:621588 6480464 Capsaicin results in increased expression of NRP1 protein CTD PMID:22150557 capsaicin multiple interactions ISO RGD:621588 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of NRP1 protein] more ... CTD PMID:22150557 carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of NRP1 mRNA CTD PMID:22634333 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25620056 CGP 52608 multiple interactions ISO RGD:733081 6480464 CGP 52608 promotes the reaction [RORA protein binds to NRP1 gene] CTD PMID:28238834 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of NRP1 mRNA CTD PMID:20938992 ciguatoxin CTX1B affects expression EXP 6480464 Ciguatoxins affects the expression of NRP1 mRNA CTD PMID:18353800 cisplatin multiple interactions ISO RGD:733081 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of NRP1 mRNA CTD PMID:21858171 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of NRP1 mRNA CTD PMID:17585979 clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of NRP1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NRP1 mRNA] CTD PMID:17585979 cobalt dichloride decreases expression ISO RGD:733081 6480464 cobaltous chloride results in decreased expression of NRP1 mRNA CTD PMID:19320972 , PMID:19376846 cobalt dichloride decreases expression ISO RGD:621588 6480464 cobaltous chloride results in decreased expression of NRP1 mRNA CTD PMID:24386269 cocaine increases expression ISO RGD:621588 6480464 Cocaine results in increased expression of NRP1 mRNA CTD PMID:15691709 copper atom multiple interactions ISO RGD:733081 6480464 [Disulfiram binds to Copper] which results in increased expression of NRP1 mRNA, [NSC 689534 binds to Copper] which results in increased expression of NRP1 mRNA CTD PMID:20971185 , PMID:24690739 copper atom multiple interactions EXP 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of NRP1 mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:733081 6480464 [Disulfiram binds to Copper] which results in increased expression of NRP1 mRNA, [NSC 689534 binds to Copper] which results in increased expression of NRP1 mRNA CTD PMID:20971185 , PMID:24690739 copper(0) multiple interactions EXP 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of NRP1 mRNA CTD PMID:15467011 cyclophosphamide decreases expression EXP 6480464 Cyclophosphamide results in decreased expression of NRP1 mRNA CTD PMID:15331540 cyclophosphamide increases expression ISO RGD:621588 6480464 Cyclophosphamide results in increased expression of NRP1 mRNA CTD PMID:18632792 cyclosporin A affects expression ISO RGD:733081 6480464 Cyclosporine affects the expression of NRP1 mRNA CTD PMID:20106945 cyclosporin A decreases expression ISO RGD:733081 6480464 Cyclosporine results in decreased expression of NRP1 mRNA CTD PMID:27989131 cyclosporin A increases expression ISO RGD:733081 6480464 Cyclosporine results in increased expression of NRP1 mRNA CTD PMID:21632981 cytarabine multiple interactions EXP 6480464 [2, 2-bis(4-glycidyloxyphenyl)propane co-treated with Cytarabine] results in decreased expression of NRP1 mRNA CTD PMID:23264188 depsipeptide multiple interactions ISO RGD:733081 6480464 [decitabine co-treated with Depsipeptides] results in decreased expression of NRP1 mRNA CTD PMID:17064661 dexamethasone multiple interactions ISO RGD:733081 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRP1 mRNA CTD PMID:28628672 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NRP1 mRNA CTD PMID:29950665 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of NRP1 mRNA CTD PMID:21266533 dibutyl phthalate decreases expression ISO RGD:621588 6480464 Dibutyl Phthalate results in decreased expression of NRP1 mRNA CTD PMID:21266533 diclofenac increases expression EXP 6480464 Diclofenac results in increased expression of NRP1 mRNA CTD PMID:26934552 dicrotophos decreases expression ISO RGD:733081 6480464 dicrotophos results in decreased expression of NRP1 mRNA CTD PMID:28302478 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of NRP1 mRNA CTD PMID:14664709 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NRP1 mRNA CTD PMID:30529165 disodium selenite multiple interactions EXP 6480464 [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of NRP1 mRNA CTD PMID:23274088 disulfiram multiple interactions ISO RGD:733081 6480464 [Disulfiram binds to Copper] which results in increased expression of NRP1 mRNA CTD PMID:24690739 dorsomorphin multiple interactions ISO RGD:733081 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects response to substance ISO RGD:733081 6480464 NRP1 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin decreases expression ISO RGD:733081 6480464 Doxorubicin results in decreased expression of NRP1 mRNA CTD PMID:29803840 entinostat increases expression ISO RGD:733081 6480464 entinostat results in increased expression of NRP1 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:733081 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP1 mRNA CTD PMID:27188386 enzacamene increases expression ISO RGD:733081 6480464 enzacamene results in increased expression of NRP1 mRNA CTD PMID:30597193 ethanol decreases expression ISO RGD:621588 6480464 Ethanol results in decreased expression of NRP1 mRNA CTD PMID:15353170 ethanol increases expression EXP 6480464 Ethanol results in increased expression of NRP1 mRNA CTD PMID:30319688 ethanol affects expression EXP 6480464 Ethanol affects the expression of NRP1 mRNA CTD PMID:22198099 , PMID:30319688 ethanol decreases expression ISO RGD:733081 6480464 Ethanol results in decreased expression of NRP1 protein CTD PMID:20621659 fenthion increases expression EXP 6480464 Fenthion results in increased expression of NRP1 mRNA CTD PMID:34813904 ferric oxide decreases expression EXP 6480464 ferric oxide analog results in decreased expression of NRP1 mRNA CTD PMID:25086211 flavonoids increases expression ISO RGD:621588 6480464 Flavonoids results in increased expression of NRP1 mRNA CTD PMID:18035473 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of NRP1 mRNA CTD PMID:20938992 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of NRP1 mRNA CTD PMID:25629700 folic acid increases expression EXP 6480464 Folic Acid results in increased expression of NRP1 mRNA CTD PMID:25006883 fulvestrant decreases expression ISO RGD:733081 6480464 Fulvestrant results in decreased expression of NRP1 mRNA CTD PMID:31646340 fulvestrant multiple interactions ISO RGD:733081 6480464 Cadmium inhibits the reaction [Fulvestrant results in decreased expression of NRP1 mRNA] more ... CTD PMID:31646340 furan increases methylation ISO RGD:621588 6480464 furan results in increased methylation of NRP1 gene CTD PMID:22079235 gemcitabine decreases response to substance ISO RGD:733081 6480464 NRP1 protein results in decreased susceptibility to Gemcitabine CTD PMID:15956974 genistein affects expression ISO RGD:733081 6480464 Genistein affects the expression of NRP1 mRNA CTD PMID:16399490 gentamycin increases expression ISO RGD:621588 6480464 Gentamicins results in increased expression of NRP1 mRNA CTD PMID:22061828 graphite affects expression ISO RGD:621588 6480464 Graphite affects the expression of NRP1 mRNA CTD PMID:29933104 hypochlorous acid increases expression EXP 6480464 Hypochlorous Acid results in increased expression of NRP1 mRNA CTD PMID:19376150 indoles increases expression ISO RGD:621588 6480464 Indoles results in increased expression of NRP1 mRNA CTD PMID:20521778 indoles decreases expression ISO RGD:621588 6480464 Indoles results in decreased expression of NRP1 mRNA CTD PMID:20521778 indometacin multiple interactions ISO RGD:733081 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRP1 mRNA CTD PMID:28628672 ivermectin decreases expression ISO RGD:733081 6480464 Ivermectin results in decreased expression of NRP1 protein CTD PMID:32959892 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of NRP1 mRNA CTD PMID:20938992 leflunomide increases expression ISO RGD:621588 6480464 leflunomide results in increased expression of NRP1 mRNA CTD PMID:24136188 leflunomide increases expression ISO RGD:733081 6480464 leflunomide results in increased expression of NRP1 mRNA CTD PMID:28988120 manganese atom increases expression ISO RGD:733081 6480464 Manganese results in increased expression of NRP1 mRNA CTD PMID:17175027 manganese(0) increases expression ISO RGD:733081 6480464 Manganese results in increased expression of NRP1 mRNA CTD PMID:17175027 manganese(II) chloride increases expression ISO RGD:733081 6480464 manganese chloride results in increased expression of NRP1 mRNA CTD PMID:17175027 melphalan decreases expression ISO RGD:733081 6480464 Melphalan results in decreased expression of NRP1 mRNA CTD PMID:22363485 mercury dibromide increases expression ISO RGD:733081 6480464 mercuric bromide results in increased expression of NRP1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:733081 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP1 mRNA CTD PMID:27188386 methotrexate increases expression ISO RGD:733081 6480464 Methotrexate results in increased expression of NRP1 mRNA CTD PMID:21678067 Morroniside increases expression ISO RGD:621588 6480464 morroniside results in increased expression of NRP1 protein CTD PMID:24979385 N-acetylsphingosine multiple interactions ISO RGD:733081 6480464 sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of NRP1 mRNA] CTD PMID:15741222 N-methyl-N'-nitro-N-nitrosoguanidine increases expression ISO RGD:621588 6480464 Methylnitronitrosoguanidine results in increased expression of NRP1 mRNA CTD PMID:15120970 naproxen multiple interactions ISO RGD:621588 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of NRP1 protein], Naproxen inhibits the reaction [Capsaicin results in increased expression of NRP1 protein] CTD PMID:22150557 nickel dichloride decreases expression EXP 6480464 nickel chloride results in decreased expression of NRP1 mRNA CTD PMID:12839937 nitrobenzenes increases expression ISO RGD:621588 6480464 Nitrobenzenes analog results in increased expression of NRP1 mRNA CTD PMID:19784758 oxaliplatin increases expression ISO RGD:733081 6480464 oxaliplatin results in increased expression of NRP1 protein CTD PMID:18790786 oxaliplatin multiple interactions ISO RGD:621588 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of NRP1 mRNA CTD PMID:25729387 p-menthan-3-ol increases expression ISO RGD:733081 6480464 Menthol results in increased expression of NRP1 mRNA CTD PMID:26760959 paclitaxel increases expression ISO RGD:733081 6480464 Paclitaxel results in increased expression of NRP1 mRNA CTD PMID:19682730 panobinostat multiple interactions ISO RGD:733081 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP1 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:733081 6480464 panobinostat results in increased expression of NRP1 mRNA CTD PMID:26272509 paracetamol multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of NRP1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NRP1 mRNA] CTD PMID:17585979 paracetamol decreases expression ISO RGD:733081 6480464 Acetaminophen results in decreased expression of NRP1 mRNA CTD PMID:21420995 , PMID:29067470 paracetamol increases expression ISO RGD:621588 6480464 Acetaminophen results in increased expression of NRP1 mRNA CTD PMID:19784758 paracetamol affects expression ISO RGD:621588 6480464 Acetaminophen affects the expression of NRP1 mRNA CTD PMID:19784758 paracetamol decreases expression ISO RGD:621588 6480464 Acetaminophen results in decreased expression of NRP1 mRNA CTD PMID:19784758 , PMID:33387578 PD 0325901 multiple interactions ISO RGD:733081 6480464 [mirdametinib co-treated with (+)-JQ1 compound] results in decreased expression of NRP1 mRNA CTD PMID:25119042 PD 0325901 decreases expression ISO RGD:733081 6480464 mirdametinib results in decreased expression of NRP1 mRNA CTD PMID:25119042 perfluorooctane-1-sulfonic acid affects expression EXP 6480464 perfluorooctane sulfonic acid affects the expression of NRP1 mRNA CTD PMID:19429403 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:621588 6480464 perfluorooctane sulfonic acid results in decreased expression of NRP1 mRNA CTD PMID:19162173 perfluorooctanoic acid affects expression EXP 6480464 perfluorooctanoic acid affects the expression of NRP1 mRNA CTD PMID:19429403 perfluorooctanoic acid decreases expression ISO RGD:621588 6480464 perfluorooctanoic acid results in decreased expression of NRP1 mRNA CTD PMID:19162173 phenobarbital multiple interactions EXP 6480464 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of NRP1 mRNA] CTD PMID:19482888 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of NRP1 mRNA CTD PMID:19482888 , PMID:23091169 phenylmercury acetate increases expression ISO RGD:733081 6480464 Phenylmercuric Acetate results in increased expression of NRP1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:733081 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP1 mRNA CTD PMID:27188386 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of NRP1 mRNA CTD PMID:18301758 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of NRP1 mRNA CTD PMID:23811191 piroxicam multiple interactions ISO RGD:733081 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of NRP1 mRNA CTD PMID:21858171 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:621588 6480464 Pregnenolone Carbonitrile results in decreased expression of NRP1 mRNA CTD PMID:19162173 progesterone multiple interactions ISO RGD:733081 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of NRP1 mRNA CTD PMID:20660070 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of NRP1 mRNA CTD PMID:21278054 Ptaquiloside multiple interactions EXP 6480464 [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of NRP1 mRNA CTD PMID:23274088 quercetin affects expression ISO RGD:733081 6480464 Quercetin affects the expression of NRP1 mRNA CTD PMID:21632981 quercetin decreases expression ISO RGD:733081 6480464 Quercetin results in decreased expression of NRP1 mRNA CTD PMID:30152185 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of NRP1 mRNA CTD PMID:19304788 rotenone increases expression ISO RGD:733081 6480464 Rotenone results in increased expression of NRP1 mRNA CTD PMID:29955902 sarin decreases expression ISO RGD:733081 6480464 Sarin results in decreased expression of NRP1 mRNA CTD PMID:19522546 sarin increases expression ISO RGD:733081 6480464 Sarin results in increased expression of NRP1 mRNA CTD PMID:19522546 SB 431542 multiple interactions ISO RGD:733081 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 senecionine decreases expression EXP 6480464 senecionine results in decreased expression of NRP1 protein CTD PMID:35357534 serpentine asbestos increases expression ISO RGD:733081 6480464 Asbestos, Serpentine results in increased expression of NRP1 mRNA CTD PMID:29523930 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of NRP1 mRNA CTD PMID:19073995 simvastatin decreases response to substance ISO RGD:733081 6480464 NRP1 SNP results in decreased susceptibility to Simvastatin CTD PMID:21483694 sodium arsenate increases expression EXP 6480464 sodium arsenate results in increased expression of NRP1 mRNA CTD PMID:21795629 sodium arsenate multiple interactions ISO RGD:733081 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of NRP1 mRNA CTD PMID:32525701 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of NRP1 protein CTD PMID:29044176 , PMID:33290778 sodium dichromate decreases expression ISO RGD:733081 6480464 sodium bichromate results in decreased expression of NRP1 mRNA CTD PMID:17685462 Soman increases expression ISO RGD:621588 6480464 Soman results in increased expression of NRP1 mRNA CTD PMID:19281266 sotorasib multiple interactions ISO RGD:733081 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of NRP1 mRNA CTD PMID:36139627 sphingosine 1-phosphate multiple interactions ISO RGD:733081 6480464 sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of NRP1 mRNA], sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of NRP1 mRNA] CTD PMID:15741222 succimer multiple interactions EXP 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NRP1 mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NRP1 mRNA CTD PMID:21641980 , PMID:26378955 succimer multiple interactions ISO RGD:733081 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NRP1 mRNA CTD PMID:26378955 sumatriptan multiple interactions ISO RGD:621588 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of NRP1 protein], Sumatriptan inhibits the reaction [Capsaicin results in increased expression of NRP1 protein] CTD PMID:22150557 sunitinib decreases expression ISO RGD:733081 6480464 Sunitinib results in decreased expression of NRP1 mRNA CTD PMID:31533062 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of NRP1 mRNA CTD PMID:20937368 temozolomide decreases expression ISO RGD:733081 6480464 Temozolomide results in decreased expression of NRP1 mRNA CTD PMID:31758290 Tesaglitazar increases expression ISO RGD:621588 6480464 tesaglitazar results in increased expression of NRP1 mRNA CTD PMID:21515302 testosterone multiple interactions ISO RGD:621588 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NRP1 mRNA CTD PMID:32741896 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of NRP1 mRNA CTD PMID:17484886 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of NRP1 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 [PANX1 protein co-treated with Carbon Tetrachloride] affects the expression of NRP1 mRNA CTD PMID:29987408 thalidomide multiple interactions ISO RGD:733081 6480464 sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of NRP1 mRNA] CTD PMID:15741222 thioacetamide increases expression ISO RGD:621588 6480464 Thioacetamide results in increased expression of NRP1 mRNA CTD PMID:19784758 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of NRP1 mRNA CTD PMID:23557971 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NRP1 mRNA CTD PMID:29950665 toluene decreases expression ISO RGD:621588 6480464 Toluene results in decreased expression of NRP1 mRNA CTD PMID:22166486 toluene increases expression ISO RGD:621588 6480464 Toluene results in increased expression of NRP1 mRNA CTD PMID:22166486 , PMID:22967744 toluene 2,4-diisocyanate increases expression EXP 6480464 Toluene 2, 4-Diisocyanate results in increased expression of NRP1 protein CTD PMID:27103660 topotecan multiple interactions ISO RGD:621588 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of NRP1 mRNA CTD PMID:25729387 topotecan decreases expression ISO RGD:621588 6480464 Topotecan results in decreased expression of NRP1 mRNA CTD PMID:25729387 trametinib multiple interactions ISO RGD:733081 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of NRP1 mRNA CTD PMID:36139627 trichostatin A increases expression ISO RGD:733081 6480464 trichostatin A results in increased expression of NRP1 mRNA, trichostatin A results in increased expression of NRP1 protein CTD PMID:16330548 more ... trichostatin A affects expression ISO RGD:733081 6480464 trichostatin A affects the expression of NRP1 mRNA CTD PMID:28542535 trichostatin A multiple interactions ISO RGD:733081 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP1 mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:733081 6480464 Triclosan results in decreased expression of NRP1 mRNA CTD PMID:30510588 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of NRP1 mRNA CTD PMID:28973697 troglitazone increases expression ISO RGD:733081 6480464 troglitazone results in increased expression of NRP1 mRNA CTD PMID:19140230 , PMID:25572481 urethane decreases expression ISO RGD:733081 6480464 Urethane results in decreased expression of NRP1 mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:733081 6480464 Valproic Acid results in increased expression of NRP1 mRNA CTD PMID:24383497 more ... valproic acid decreases expression ISO RGD:733081 6480464 Valproic Acid results in decreased expression of NRP1 mRNA CTD PMID:28001369 , PMID:29154799 valproic acid multiple interactions ISO RGD:733081 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP1 mRNA CTD PMID:27188386 vinclozolin affects expression ISO RGD:621588 6480464 vinclozolin affects the expression of NRP1 mRNA CTD PMID:19015723 vinclozolin decreases methylation ISO RGD:621588 6480464 vinclozolin results in decreased methylation of NRP1 gene CTD PMID:31682807 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of NRP1 mRNA CTD PMID:20857495 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of NRP1 mRNA CTD PMID:20857495
